These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 15767761

  • 21. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [Abstract] [Full Text] [Related]

  • 22. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age.
    Hokken-Koelega A, van Pareren Y, Arends N.
    Horm Res; 2005 Oct; 64 Suppl 3():95-9. PubMed ID: 16439851
    [Abstract] [Full Text] [Related]

  • 23. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 24. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F, Hokken-Koelega A.
    Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
    [Abstract] [Full Text] [Related]

  • 25. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005 Apr; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 26. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 27. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R, Martin DD, Schönau E, Ranke MB.
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [Abstract] [Full Text] [Related]

  • 28. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database).
    Geffner M, Lundberg M, Koltowska-Häggström M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5435-40. PubMed ID: 15531494
    [Abstract] [Full Text] [Related]

  • 29. Recombinant human growth hormone in short children born small for gestational age. German Study Group.
    Butenandt O, Lang G.
    J Pediatr Endocrinol Metab; 1997 Nov; 10(3):275-82. PubMed ID: 9388818
    [Abstract] [Full Text] [Related]

  • 30. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
    [Abstract] [Full Text] [Related]

  • 31. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A, Simon D, Czernichow P.
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [Abstract] [Full Text] [Related]

  • 32. Growth in pre-pubertal children with myelomeningocele (MMC) on growth hormone (GH): the KIGS experience.
    Trollmann R, Bakker B, Lundberg M, Doerr HG.
    Pediatr Rehabil; 2006 Mar; 9(2):144-8. PubMed ID: 16449073
    [Abstract] [Full Text] [Related]

  • 33. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.
    August GP, Julius JR, Blethen SL.
    Pediatrics; 1998 Aug; 102(2 Pt 3):512-6. PubMed ID: 9685455
    [Abstract] [Full Text] [Related]

  • 34. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Aug; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 35. Height gain at adult-height age in 184 short patients treated with growth hormone from prepubertal age to near adult-height age is not related to GH secretory status at GH therapy onset.
    Carrascosa A, Audí L, Fernández-Cancio M, Yeste D, Gussinye M, Campos A, Albisu MA, Clemente M, Bel J, Nosás R, Rabanal M, Del Pozo C, Gómez JM, Mesa J, Group for Short Stature Study.
    Horm Res Paediatr; 2013 Aug; 79():145-56. PubMed ID: 23548791
    [Abstract] [Full Text] [Related]

  • 36. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of long-term continuous growth hormone treatment of children born small for gestational age.
    Hokken-Koelega A, van Pareren Y, Arends N, Boonstra V.
    Horm Res; 2004 May; 62 Suppl 3():149-54. PubMed ID: 15539818
    [Abstract] [Full Text] [Related]

  • 38. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ, van der Kaay DC, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [Abstract] [Full Text] [Related]

  • 39. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Dahlgren J, Bjarnason R, Rosberg S, Carlsson LM, Carlsson B, Albertsson-Wikland K.
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [Abstract] [Full Text] [Related]

  • 40. Puberty in growth hormone-treated children born small for gestational age (SGA).
    Boonstra V, van Pareren Y, Mulder P, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5753-8. PubMed ID: 14671164
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.